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Summary: Normal human adrenocortical cells (from multi-organ donors) were incubated with corticotropin
(tetracosactide), highly purified human ß-lipotropin, synthetic human ß-lipotropin, y2-melanocyte stimulating
hormone and ß-endorphin. Corticotropin stimulated cortisol, aldosterone and 18-hydroxycorticosterone
production starting at "12—10"11 mol/1 in normal adrenocortical cells. Purified human ß-lipotropin also
stimulated steroidogenesis but 100 — lOOOfold higher concentrations of the peptide were needed. In contrast,
synthetic human ß-lipotropin was without any effect on steroid production up to concentrations of 10~?
mol/1. Synthetie ß-lipotropin (5 10~10 mol/1) did not significantly change the dose-response curve for
corticotropin (10~13 mol/1—10~9 mol/1) versus the three steroids ineasured. y2-Melanotropin and ß-endorphin
(10~6 mol/1) stimulated the secretion of cortisol, but not of aldosterone.
Since synthetic human ß-lipotropin has no effect on human adrenocortical cells, the purified ß-lipotropin
must be contaminated with traces of eorticotropin. Since pathologically elevated levels of proopipmelanocort-
in-derived peptides will rarely exceed plasma concentrations of 10~10 mol/1, our findings in vitro do not
support a physiological or pathophysiological role of the peptides examined in the regulation of adrenal
steroid secretion.
Synthetic ovine ß-lipotropin (3) and extracted ovine
Some experimental data support a role of pituitary and human ß-lipotropin (4) were shown to stimulate
factors other than corticotropin in aldosterone regu- aldosterone secretion, Shanker & Sharma (5) de-
lation, especially during sodium depletion (l, 2). seribed a stimulatory effect of synthetic ß-endorphin
Stimülatoiy effects of proopiomelanocortin-derived on aldosterone secretion which could not be con-
peptides on isolated rat adrenal cells have recently firmed by Matsuoka et al. (3). Synthetic Lys-y3-me-
been reported: lanotropin was found to enhance the corticosterone-
stimulating effect of corticotropin (6). AI Dujaili et
..... al. (7) found that human pro-y-melanotropin acts
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Reports on effects of proopiomelanocortin-derived
peptides on human adrenal cells are scanty. AI Dujaili
et al. (7) described aldosterone and cortisol stimulat-
ing activity of pro-y-melanotropin on human adrenal
cells. Lis et al. (8) reported on aldosterone Stimulation
by Y3-melanotropin and the 16 K N-terminal se-
quence of proopiomelanocortin in aldosteronoma
cells. Pham-Huu-Trung et al. (9) on the other band,
demonstrated an aldosterone-stimulating effect of ex-
tracted human ß-lipotropin, extracted N-terminal
proopiomelanocortin-peptide and synthetic y3-mela-
notropin in normal human adrenal cells and in aldos-
teronoma cells.
In the study presented here, we investigated steroido-
genic effects of synthetic ß-lipotropin, y2-melanotro-
pin and ß-endorphin in comparison with those of
corticotropin on normal human adrenocortical cells.
To enable comparison with the above-mentioned lit-
erature, we investigated the steroidogenic effect of
purified human ß-lipotropin äs well.
incubation, the decanted cell suspensions were centrifuged at
4000g, and the supernatants were stored a t —20 °C until ste-
roid assays were performed.
Cortisol, aldosterone and 18-hydroxycorticosterone were quan-
tified according to Schöneshöfer et al. (13). In brief, tritiated
probes of the three steroids were added to the samples, which
were then twice extracted with 5 ml dichloromethane. This was
followed by paper chromatogra!phy, loc^lization pf the steroids
on the paper by tritium scanning and elution with 5 ml meth-
anol. The dried eluates were dissolved in the radioimmunoassay
(RIA)-buffer and speciflc antibodies were used for quantifica-
tion by RIA. The aldosterone antibody was given to us by the
National Institute of Health, Bethesda, Maryland, USA. The
cortisol antibody is a gift of Dr. Vecsei, Heidelberg, Germany,
and the antibody directed against 18-hydroxycorticosterone
was prepared in our laboratory (14). The intraassay coeffioients
of Variation for the determination of cortisol, aldosterone and
18-hydroxycorticosterone were 5.1%, 11.0% and 6.0% respec-
tively, the interassay coefHcients pf Variation 20.4%, 23.5%
and 18.8% respectively. The sensitivity of the assays (90% B0)
was 75 pmol/1 cortisol, 85 pmol/1 aldosterone and 104 pniol/1
18-hydroxycorticosterone. In most experiments, cortisol con-
centrations were measured without paper chromatography,
after comparative measurements had shown that cortisol levels
following chromatography were only 10% lower, and the coefil-
cient of correlation between the two methods was 0.83.
Materials and Methods
Human ß-lipotropin was isolated and purified, äs published
previously, by carboxymethylcellulose chromatography and gel
filtration, and the homogeneity was tested by paper and disc
electrophoresis, and NH2-terminal analysis (10). Human ß-
lipotropin was synthesized äs published elsewhere (11). Syn-
thetic human (Z)-Ala2)ß-endorphin and y2-melanotropin were
purchased from Peninsula Lab., California, USA. Homogeneity
was tested by high performance liquid chromatography
(HPLC), thin layer chromatography (TLC), amino acid analysis
and high voltage electrophoresis.
ß1-24-Cortico tropin (tetracosactide) was purchased from GIB A
(Synacthen®). Human adrenal glands were obtained from 10
multi-organ-donors. Immediately after the removal, the glands
were placed into cold (4 °C) saline (9 g/l NaCl). As soon äs
possible, not later than 90 min after the end of blood perfusion,
adrenal glands were cut into slices and the outer, subcapsular
cell layers were obtained by tangential section of the material
for cell preparations. In 6 adrenal cell preparations, the steroid
stimulating effect of corticotropin, purified human ß-lipotropin
and of synthetic Y2-melanotropin and ß-endorphin was investi-
gated (fig. 1). Since extracted ß-lipotropin stimulated cortisol
secretion in 100—1000 fold higher concentrations than cortico-
tropin, the suspicion arose that the peptide may be contami-
nated with traces of corticotropin. Therefore, we investigated
the effect of synthetic human ß-lipotropin alone and in conjunc-
tion with corticotropin in 4 further experiments with normal
human adrenocortical cells (fig. 2). The detailed procedure of
cell preparation and incubation in this laboratory has been
described in detail by Belmega et al. (12). About 2 l O5 cells
(about 90% viable according to trypan-blue exclusion) were
incubated in 2 ml medium for 2 hours in a metabolic shaker
(Warburg Apparat, type 585G, Braun Melsungen, FRG) under
a stream of 95% O2 and 5% CO2. The controls were always
incubated in duplicate or triplicate. All incubations with corti-
cotropin and with synthetic human ß-lipotropin were also car-
ried out in duplicate. Incubations in one vessel only were
performed when the effects of purified human ß-lipotropin,
 2-
melanotropin and ß-endorphin were tested, because the number
of incubation vessels in the metabolic shaker was limited to 28
and the supply of human ß-lipotropin was small. After the
Results
Sinee the adrenals from cadaver kidney donors could
not be obtained under standardized conditions, basal
secretory rates and steroid Stimulation by the peptides
investigated exhibited a large variability. Basal steroid
secretions are shown in table l, while the results in
the figures are expressed äs relative changes over
control levels. The significance of differences between
controls and stimulated samples was calculated using
the paired t-test.
Tab. 1. Unstimulated basal steroid production rates (ng/105
cells per 2 hours) of 10 adrenals frona different donors.
Range SEM
Cortisol
Aldosterone
1 8-Hydroxycorticosterone
28 -415
0.16- 9.78
0.14- 23.2
124
2.5
3.57
42.6
1.23
2.65
Figure l shows the results of six experiments with
adrenocortical cell incubations, where dose-respöüse
curves with purified human ß-lipotropin, synthetic ß-
endorphin and synthetic Y2-melanotropin were com-
pared with a high and low dose of corticotropin.
Corticotropin (10~9 mol/1) stimulated cortisol five-
to sixfold, aldosterone about twofQld and 18-hy-
droxycorticosterone about threefold. ß-endorphin
and y2-melanotropin (10~6 rnol/1) stimulated cortisol
significantly, but not the zona glomerulosa steroids.
At 10~7—10~6 mol/1 extracted human ß-lipotropin
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Fig. 1. EfTects of corticotropin 1—24 (o), highly purified
human -lipotropin (Δ), synthetic -endorphin (D), and
y2-melanotropin (O) in six experiments with adreno-
cortical cells from cadaver kidney donors. Production
rates of cortisol, aldosterone and 18-hydroxycortico^
sterone in unstimulated control vials (duplicate or tripli-
cate) are defmed s 1.0. The increase (multiples ±
SEM) is shown.
* = p < 0.05, ** == p < 0.01 (Studenfs t-test) com-
pared with control incubations.
stimulated all three steroids to the saine extent s
10"~9 mol/l corticptropin, b t changes in aldosterone
and 18*hydroxycorticpsterone wefe not significantly
different from the controls (p > 0.05) due to larger
variability.
Figure 2 demonstrates the results of four experiments
with adrenal cells, where dose^response curves with
corticotropin and synthetic human -lipotropin were
set up. Synthetic human -lipotropin had no effect
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Fig. 2. EfTects of corticotropin l — 24 of (o), synthetic human
-lipotropin (Δ) and 5 · 10~10 mol/l synthetic human
-lipotropin together with rising concentrations of corti-
cotropin l'—24 (a) on production of Cortisol, aldo-
sterone and 18-hydroxycorticosterone in four prepara-
tions of adrenocortical cells from cadaver kidney do-
nors. Mean changes (multiples ± SEM) of steroid pro-
duction over control levels (1.0) are shown.
* = p ^ 0.05, ** = p < 0.01 (Studenfs t-test) com-
pared with control incubations.
whatsoever on steroid production up to concentra-
tions of 10~7 mol/l. Corticotropin started to stimulate
cortisol at 10~12 mol/l. The Cortisol rise at 10~9 mol/l
corticotropin was probably close to the maximum.
The Stimulation curves of aldosterone and 18-hy-
droxycorticosterone were flatter with the threshold
cx>ncentration of corticotropin at about 10~n mol/l.
When 5 χ l O"10 mol/l synthetic human -lipotropin
was added to all incubates, the dose response curve
(corticotropin vs steroid production) was not signifi-
caiitly modified, although small influences of -lipo-
tropin may have remained undetected because of the
large variability of the individual cell preparations.
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Discussion
The basal secretory rates of adrenocortical cells are
similar to those reported recently by Belmega at al.
(12). However, the cell preparations used in the pre-
sent study were less sensitive to corticotropin. Basal
and stimulated levels of 18-hydroxycorticosterone
were about two- to threefold higher than those of
aldosterone. A similar ratio between the two zona
glomerulosa products is also found in plasma (l 5).
While cortisol secretion is markedly stimulated by
corticotropin in isolated human adrenocortical cells,
the Stimulation of aldosterone and 18-hydroxycorti-
costerone is less impressive than that found in vivo.
This may be due to functional changes during glo-
merulosa cell preparation (16). Isolated cells from the
zona glomerulosa of rat adrenals are easier to handle,
and the results are probably more reproducible than
those with human zona glomerulosa cell prepara-
tions. However, it is doubtful whether findings in the
rat are always transferable to human biology.
*· \
We found that purified human ß-lipotropin stimu-
lated cortisol and the zona glomerulosa steroids to
the same extent äs corticotropin, although at 100 —
lOOOfold higher concentrations. A similar observa-
tion was made by Washburn et al. (4) using rat adre-
nocortical cells. Synthetic ß-lipotropin (ovine) was
inactive in the rat (4), just äs human synthetic ß-
lipotropin was inactive in our human adrenocortical
cell preparations. The discrepancy between the effects
of extracted human ß-lipotropin and synthetic human
ß-lipotropin may be due to small amounts of cortico-
tropin present in the extracted peptide preparation.
This may also explain the stimulatory effect of ex-
tracted human ß-lipotropin in aldosteronoma cells
reported by Pham-Huu-Trung et al. (9).
According to Smith et al. (17) ß-lipotropin concentra-
tions in normal human plasma are about 10~u mol/1.
Following insulin-induced hypoglycaemia, ß-lipotro-
pin levels rise in the same way äs those of corticotro-
pin. In untreated patients with Addison's disease, ß-
lipotropin levels may rise up to fiftyfold above nor-
mal. If the activity of extracted human ß-lipotropin
at 10~9 mol/1 (threshold dose for cortisol and 18-
hydroxycorticosterone) was not due to contamination
with corticotropin, extremely high pathological
plasma concentrations of ß-lipotropin might exert
some biological effect on the adrenal gland, äs for
example in patients with Cushing's syndrome due to
ectopic corticotropin (and ß-lipotropin) secretion. A
physiological contribution of ß-lipotropin to the re-
gulation of adrenocortical function, however, is un-
likely. Our second experiment, where cells were incu-
bated with corticotropin plus ß-lipotropin, were car-
ried out with the synthetic human peptide which had
no stefoidogenic potency of its own. Nö modification
of the effect of corticotropin on the three steroids
was found. .
 f
y2-Melanotropin äs well äs ß-endorphin had a small
stimulatory effect on cortisol secretion at the very
high cpmcentration of 10~6 mol/1, while the zona
glomerulosa steroids remained unchanged. This con-
centration seems to be far outside the physiological
ränge: Hope et al. (18) found the molar concentration
of the immunoreactive N^terminal portion of proopio-
melanocortin in human plasma to be about two- to
threefold higher than those of corticotropin. Even in
plasmas from patients with greatly elevated cortico-
tropin concentrations (ectopic corticotropin syn-
drome, Addison's disease), immunoreactive N-ter^
minal portion of proopiomelanocortin was below
10~9 mol/1. Plasma concentrations of ß-endorphin in
the human are of the same order of magnitude äs
those of corticotropin (17). A physiological role of
y^melanotropin peptides and/or ß-endorphin in the
function of the adrenal gland is therefore unlikely, if
our in vitro results are taken into accpunt. However,
Al-Dujaili et al. (7) observed a potentiating effect of
rather low concentrations of pro-y-melanotropin on
aldosterone and corticosterone secretion by isolated
superfused human and rat adrenocortical cells. Pro-
-melanotropin itself did not stimuläte steroid secre-
tion. Farese et al. (6) also described a synergistic
effect between corticotropin and Y3-melanotfopin
(corresponding to y2-melanotropin with 15 additional
Oterminal amino acids) in corticosteröne-producing
zona fasciculata cells of rats.
Recently, an in vivo stimulating effect of ß-endorphin
on aldosterone secretion was demonstrated in man
(19). An infusion rate of l g/kg · min stimulated
plasma aldosterone and renin activity and led to a
fall in plasma corticotropin and cortisol. The latter
effect may be due to Inhibition of corticotropin secre-
tion by a feedback mechanism at the level of the
hypothalamus, while the increase in aldosterone may
be mediated by the renin-angiotensiii System. In con-
trast, Kern et al. (20) found no effect on plasma
aldosterone or plasma cortisol with bolus administra-
tions of up to 15 mg ß-endorphin in four normal
human subjects. Our own in vitro results with ß-
endorphin speak against a direct effect of this peptide
on the adrenal cortex, thereby confirming the findings
ofMatsuoka et al. (3) in rat adrenal cell preparations.
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